Although a pharmacodynamic interaction with ASA leading to an increased risk of bleeding is possible, the demonstration of the efficacy and safety of prasugrel comes from patients concomitantly treated with ASA.
Kuigi farmakodünaamiline koostoime ASH- ga võib tekitada suurema veritsusohu, on efektiivsuse ja ohutuse andmed saadud patsientidelt, kes kasutavad prasugreeli koos ASH- ga.